Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001650664-25-000089

CEO sold 15,192 shares at $1.72 ($26,196)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

O'Neill Gilmore Neil · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-06-03 Sale : show line 1 in the form 10b5-1 −15,192 $1.72 $26,196 280,282 D
Open-market sales · 15,192 sh · avg $1.72 · $26,196
Loading xslF345X05/wk-form4_1749076593.xml…